Quarterly report [Sections 13 or 15(d)]

Shareholders??? Equity

v3.25.1
Shareholders’ Equity
3 Months Ended
Mar. 31, 2025
Shareholders’ Equity [Abstract]  
SHAREHOLDERS’ EQUITY

NOTE 6 – SHAREHOLDERS’ EQUITY:

 

a. As of March 31, 2025 total of 10,690 common stock are held by the company as treasury shares.

 

  b.

Total outstanding warrants as of March 31, 2025, are as follow:

 

    Number of
warrants
    Exercise
price
    Period left
in years
 
Warrants May 2023     66,127     $4.625       3.9  
Warrants December 2023     1,360,170     $1.18 - $1.47       4.5  
Warrants June 2024     1,069,647     $2 - $3.43       5.0  
Warrants July 2024     2,069,317     $2.5 - $1.75       1.75  
Other     36,942     $10.27 - $50       1.50 - 2.4  
Outstanding as of March 31, 2025     4,602,203                

 

  c. At the Market Offering Agreement:

 

On September 18, 2024, the Company entered into At the Market Offering Agreement (the “ATM Agreement”), with H.C. Wainwright & Co. (“Wainwright”), as sales agent, pursuant to which the Company may issue and sell shares of its common stock, from time to time, through Wainwright.

 

Under the ATM Agreement, Wainwright may sell shares in transactions that are deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act, as amended, or in any other method permitted by law, including in privately negotiated transactions.

 

The Company or Wainwright may suspend or terminate the ATM Agreement upon notice to the other party and subject to other conditions.

 

The Company will pay Wainwright a commission of 3.0% of the gross sales price of any common stock sold under the ATM Agreement and has agreed to provide Wainwright with customary indemnification and contribution rights. The Company will also reimburse Wainwright for certain specified expenses.

 

During the first quarter of 2025, the company issued and sold 1,394,934 shares of common stock for gross proceeds of approximately $ 1,750 thousand. Total cost related to the offering is approximately $ 170.

  d. Share-based compensation:

 

  1) A summary of the Company’s share options, granted to employees, directors, under option plans is as follows:

 

    Number
of options
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Life
 
Outstanding – January 1, 2025     62,678       4.38       3.4  
Granted    
-
     
-
      -  
Exercised    
-
     
-
      -  
Forfeited     (1,248 )     5.21       -  
                         
Outstanding – March 31, 2025     61,430       4.36       2.85  
Exercisable – March 31, 2025     58,618       3.73       2.62  

 

The majority of the Share-based compensation expenses included in the Condensed consolidated statements of comprehensive loss under General and Administrative.

 

As of March 31, 2025, the unrecognized compensation costs related to those unvested stock options are $11, which are expected to be recognized over a weighted-average period of 1 years.

 

  2) A summary of the Company’s RSUs, granted to employees, directors, under option plans is as follows:

 

    March 31, 2025  
    Number of
RSUs
    Weighted-
Average
Grant
Date Fair
Value
 
RSUs outstanding at the beginning of the year     36,254       12.38  
Granted during the period    
-
     
-
 
Vested during the period     (1,665 )     5.28  
Forfeited during the period    
-
     
-
 
Outstanding as of March 31, 2025     34,589       12.72  

 

The majority of the RSUs expenses included in the Condensed consolidated statements of comprehensive loss under General and Administrative.

 

As of March 31, 2025, the unrecognized compensation cost related to unvested RSUs totaled to approximately $ 331 and is expected to be expensed over a weighted-average recognition period of approximately 1.7 years.